During the first half of the 20th century, care at the time of delivery was primarily focused on the mother. Although newborns were observed, there was no standardized, rapid, and reproducible method to assess their condition in the first minutes of life.
This gap was especially relevant in a context where hospital births and the use of obstetric anesthesia were becoming widespread, factors that could affect the newborn's adaptation without clear criteria to measure it.
In this scenario, American physician Virginia Apgar, specializing in anesthesiology, identified a specific problem: the lack of a simple tool that would allow for the immediate assessment of the baby's condition and enable clinical decisions to be made based on objective criteria.
The Development of the Apgar Score
In 1952, Apgar introduced a neonatal assessment method based on five observable clinical parameters that could be measured in seconds and without the need for equipment:
- Heart rate
- Respiratory effort
- Muscle tone
- Responsiveness to stimuli (irritability reflex)
- Skin color
Each of these indicators is scored from 0 to 2, for a total score ranging from 0 to 10.
The evaluation is performed at one minute of life and repeated at five minutes, allowing clinicians to observe the newborn’s adaptation to the extrauterine environment and quickly detect situations that require medical intervention.
In clinical terms:
- 7 to 10 points indicate adequate adaptation
- 4 to 6 points suggest moderate distress
- 0 to 3 points represent a critical condition requiring immediate intervention
A Global Standard in Neonatal Medicine
One of the main strengths of the Apgar test is its operational simplicity. It requires no technology, can be applied in any setting—from high-complexity hospitals to resource-limited centers—and provides a common language for the medical team.
Because of these characteristics, the method was rapidly adopted worldwide and is now part of routine assessment in virtually all births. Organizations such as the World Health Organization and pediatric societies recognize it as a basic standard in the initial evaluation of the newborn.
Its implementation made it possible to standardize clinical observation, improve the early detection of complications such as perinatal asphyxia, and optimize decision-making in the first minutes of life—a critical period for neonatal survival.
Scope and limitations
Although the Apgar test is a fundamental tool, its scope is clearly defined. It was not designed to predict neurological development or the newborn’s long-term outcomes.
Its function is to assess the immediate clinical condition and the response to initial medical interventions. In this sense, a low score does not necessarily determine an unfavorable prognosis, but it does indicate the need for rapid action.
This distinction is key for its proper interpretation in medical practice.
A contribution that transformed clinical practice
The impact of the Apgar test lies not in its complexity, but in its ability to structure clinical observation at a critical moment. It introduced objective criteria where subjective assessment once prevailed and helped improve the quality of neonatal care on a global scale. More than seven decades after its development, the method remains in use and continues to be an essential tool in medicine.
Virginia Apgar’s contribution not only solved a specific problem, but also changed the way the beginning of life is evaluated: with clear, measurable criteria that can be applied in any setting.
